NCT01165996 2019-03-04
Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome
Case Comprehensive Cancer Center
Phase 1/2 Completed
Clinical Trials
1 trialsPhase 1/2 × Anemia, Refractory, with Excess of Blasts × Amplified Fragment Length Polymorphism Analysis × Clear all